Quarterly Result14 May 2026, 05:41 pm
Shree Ganesh Biotech: FY26 Revenue ₹497.05 Lakhs
AI Summary
Shree Ganesh Biotech (India) Ltd's board approved the audited financial results for the year ended March 31, 2026. Gross revenue from the sale of products stood at ₹497.05 lakhs for FY26, compared to ₹2,295.76 lakhs in the previous year. The company reported a net profit after tax of ₹37.76 lakhs for the year ended March 31, 2026.
Key Highlights
- Audited financial results for the year ended March 31, 2026, approved by the board.
- Gross revenue from product sales for FY26 is ₹497.05 lakhs.
- Net profit after tax for FY26 is ₹37.76 lakhs.
- The auditor's report has an "Unmodified Opinion".
- Board meeting commenced at 05:00 PM and concluded at 05:30 PM on May 14, 2026.